A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

Clinical trial NCT05867420 · RECRUITING

Trial details

NCT number: NCT05867420
Sponsor: AskGene Pharma, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2023-08-02
Primary completion: 2026-12-31
Enrollment: 594

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.